A global biomedical R&D fund and mechanism for innovations of public health importance

PLoS Med. 2015 May 11;12(5):e1001831. doi: 10.1371/journal.pmed.1001831. eCollection 2015 May.

¹ Access Campaign, Médecins Sans Frontières, Geneva, Switzerland.
² Institut Pasteur, Paris, France.
³ Wellcome Trust, London, United Kingdom.
⁴ Centre on Global Health Security, Chatham House, London, United Kingdom.
⁵ Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.
⁶ South Centre, Geneva, Switzerland.
⁷ INSERM, Paris, France.
⁸ Department of Health, Pretoria, South Africa.
⁹ Department of International Cooperation, China National Health and Family Planning Commission, Beijing, People's Republic of China.
¹⁰ Drugs for Neglected Diseases initiative, Geneva, Switzerland.
¹¹ Department of Global Health, School of Public Health, Peking University, Peking, China.
¹² Swiss Tropical and Public Health Institute, Basel, Switzerland.
¹³ Norwegian Institute of Public Health, Norway, University of Oslo, Olso, Norway; Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.

Abstract

Bernard Pécoul and colleagues call for the establishment of a global biomedical R&D fund as a key priority of the G7 summit in June 2015.

No funding received for this work.